author-photo

Matthew Beasley

Bristol Royal Infirmary

4

Papers

7

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

LYMRIT 37-01: UPDATED RESULTS OF A PHASE I/II STUDY OF 177 LU-LILOTOMAB SATETRAXETAN, A NOVEL CD37-TARGETED ANTIBODY- RADIONUCLIDE-CONJUGATE IN RELAPSED NHL PATIENTS

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Abstract LB-252: Efficacy and safety results of Betalutin® (177Lu-DOTA-HH1) in a phase I/II study of patients with non-hodgkin B-cell lymphoma (NHL)

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
177lu-Satetraxetan-Lilotomab in the Treatment of Patients with Indolent Non-Hodgkin B-Cell Lymphoma (NHL), Phase 1/2 Safety and Efficacy Data from Four Different Pre-Dosing Regimens

2016 Blood
Show All
- Source
- Cite
- Save
Citations (1)